Jaime Algorta
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Individual-level analysis of the efficacy of albendazole and albendazole-ivermectin fixed-dose coformulation (FDC) against Trichuris trichiura and hookworms.
Journal: Acta tropica
Published: April 01, 2025
Albendazole-ivermectin co-formulation for the treatment of Trichuris trichiura and other soil-transmitted helminths: a randomised phase 2/3 trial.
Journal: The Lancet. Infectious diseases
Published: August 23, 2024
Population Pharmacokinetics and Exposure-Response Analysis of a Fixed-Dose Combination of Ivermectin and Albendazole in Children, Adolescents, and Adults.
Journal: Clinical pharmacology and therapeutics
Published: February 26, 2024
Multicenter, international observational study on quality of life and acceptability of a vaginal contraceptive ring containing etonogestrel/ethinylestradiol 11.00/3.474 mg over six months of use.
Journal: European review for medical and pharmacological sciences
Published: October 20, 2022
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol.
Journal: Gates open research
Published: April 26, 2022
Pharmacokinetic Characterization and Comparative Bioavailability of an Innovative Orodispersible Fixed-Dose Combination of Ivermectin and Albendazole: A Single Dose, Open Label, Sequence Randomized, Crossover Clinical Trial in Healthy Volunteers.
Journal: Frontiers in pharmacology
Published: April 07, 2022
Effectiveness of tianeptine in patients with major depressive disorder and substance use disorder.
Journal: Actas espanolas de psiquiatria
Published: July 01, 2021
Tianeptine: New description of the mechanism of action and change of technical data sheet.
Journal: Revista de psiquiatria y salud mental
Published: October 23, 2019
Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg).
Journal: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
Published: January 17, 2018
Response to Sharma et al.: Long Pulmonary Residence Time and Plasma Half-Life of Tiotropium: Implications for Pharmacokinetic Bioequivalence Studies.
Journal: Clinical drug investigation
Published: June 04, 2017
Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells.
Journal: Scientific reports
Published: April 04, 2017
Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers.
Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers.
Journal: Clinical drug investigation
Published: July 30, 2016
Last Updated: 09/26/2026